REFRACTORY MYELODYSPLASTIC SYNDROMES

Clinical trials for REFRACTORY MYELODYSPLASTIC SYNDROMES explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY MYELODYSPLASTIC SYNDROMES trials appear

Sign up with your email to follow new studies for REFRACTORY MYELODYSPLASTIC SYNDROMES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope pill tested for tough blood cancers

Disease control Ongoing

This early-stage study is testing a new oral medication called AUTX-703 for adults with advanced forms of blood cancer (AML or MDS) that have returned or stopped responding to other treatments. The main goal is to find a safe dose and see how the body handles the drug. Researcher…

Matched conditions: REFRACTORY MYELODYSPLASTIC SYNDROMES

Phase: PHASE1 • Sponsor: Auron Therapeutics, Inc. • Aim: Disease control

Last updated Mar 16, 2026 15:25 UTC

REFRACTORY MYELODYSPLASTIC SYNDROMES

Get alerted when new REFRACTORY MYELODYSPLASTIC SYNDROMES trials appear

New hope pill tested for tough blood cancers